Simplex Trading, LLC Cara Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 307 shares of CARA stock, worth $141. This represents 0.0% of its overall portfolio holdings.

Number of Shares

307

Previous 3,691 91.68%

Holding current value

$141

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$0.26 - $0.38 $879 - $1,285	-3,384 Reduced 91.68%	307 $0
Q2 2024 Jul 25, 2024	SELL	$0.24 - $0.92 $232 - $892	-970 Reduced 20.81%	3,691 $0
Q1 2024 Apr 25, 2024	BUY	$0.52 - $1.05 $2,224 - $4,490	4,277 Added 1113.8%	4,661 $4,000
Q4 2023 Feb 02, 2024	SELL	$0.6 - $1.65 $2,042 - $5,616	-3,404 Reduced 89.86%	384 $0
Q3 2023 Nov 01, 2023	SELL	$1.67 - $3.33 $32,399 - $64,605	-19,401 Reduced 83.66%	3,788 $6,000
Q2 2023 Aug 04, 2023	BUY	$2.83 - $4.94 $57,765 - $100,835	20,412 Added 735.04%	23,189 $65,000
Q1 2023 Apr 27, 2023	BUY	$4.89 - $12.27 $8,445 - $21,190	1,727 Added 164.48%	2,777 $13,000
Q4 2022 Feb 02, 2023	SELL	$8.88 - $12.77 $72,833 - $104,739	-8,202 Reduced 88.65%	1,050 $11,000
Q3 2022 Nov 04, 2022	BUY	$8.24 - $12.56 $15,202 - $23,173	1,845 Added 24.91%	9,252 $86,000
Q2 2022 Aug 03, 2022	BUY	$7.45 - $13.84 $50,846 - $94,458	6,825 Added 1172.68%	7,407 $67,000
Q1 2022 May 02, 2022	SELL	$9.94 - $12.65 $38,716 - $49,271	-3,895 Reduced 87.0%	582 $7,000
Q4 2021 Feb 23, 2022	BUY	$11.99 - $18.14 $53,679 - $81,212	4,477 New	4,477 $54,000
Q2 2021 Aug 12, 2021	SELL	$12.38 - $29.19 $85,496 - $201,586	-6,906 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$15.07 - $21.71 $309,643 - $446,075	-20,547 Reduced 74.84%	6,906 $149,000
Q4 2020 Feb 02, 2021	BUY	$12.72 - $16.16 $247,798 - $314,812	19,481 Added 244.37%	27,453 $415,000
Q3 2020 Oct 14, 2020	SELL	$12.34 - $17.92 $64,859 - $94,187	-5,256 Reduced 39.73%	7,972 $101,000
Q2 2020 Jul 13, 2020	BUY	$12.39 - $17.33 $60,066 - $84,015	4,848 Added 57.85%	13,228 $226,000
Q1 2020 Apr 29, 2020	SELL	$9.12 - $17.78 $246 - $480	-27 Reduced 0.32%	8,380 $110,000
Q4 2019 Feb 05, 2020	BUY	$16.11 - $25.98 $28,450 - $45,880	1,766 Added 26.59%	8,407 $135,000
Q3 2019 Oct 15, 2019	BUY	$18.28 - $26.91 $121,397 - $178,709	6,641 New	6,641 $121,000
Q2 2019 Jul 26, 2019	SELL	$17.68 - $21.57 $9,847 - $12,014	-557 Closed	0 $0
Q1 2019 Apr 18, 2019	SELL	$14.41 - $19.64 $207,345 - $282,599	-14,389 Reduced 96.27%	557 $0
Q4 2018 Jan 16, 2019	SELL	$12.45 - $23.47 $46,662 - $87,965	-3,748 Reduced 20.05%	14,946 $194,000
Q3 2018 Oct 23, 2018	BUY	$17.57 - $23.95 $328,453 - $447,721	18,694 New	18,694 $447,000
Q1 2018 Apr 26, 2018	SELL	$11.77 - $16.08 $148,937 - $203,476	-12,654 Closed	0 $0
Q4 2017 Jan 10, 2018	BUY	$11.86 - $14.08 $145,308 - $172,508	12,252 Added 3047.76%	12,654 $154,000
Q3 2017 Oct 25, 2017	BUY	$12.6 - $16.34 $5,065 - $6,568	402	402 $5,000

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $24.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Cara Therapeutics, Inc. Transaction History